Notably, this balance shifts throughout tumor progression: early-stage NSCLC, characterized by low TGF-β and high IL-6, favors Th17 polarization, whereas advanced stages, enriched in TGF-β, promote Foxp3 expression and Treg dominance (124–126). This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.